
PTC Therapeutics, Inc. (PTCT) earnings
- Healthcare
- NASDAQ
- Market cap$4.7B
Next report
2027-02-18
In 88 daysQ4 FY2026AMC· Expected date
- EPS consensus
- 0.35
- -1.36 – 1.893 analysts
- Revenue consensus
- $330M
Latest result
24 days ago+16.8%Revenue Beat
Estimate recorded after the release
2026-10-29Q3 FY2026AMC
- EPS
- Reported / estimate-0.62 / 0.14
- Revenue
- $358M / $306M
Stock reaction
-6.97%
-5.19 pts vs SPY
Session 2026-10-30
Recent quarters
Latest 3 quartersRevenue and stock reaction
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-10-29 | -0.62 / 0.14 -532.4%†¶ | $358M / $306M +16.8%¶ | -6.97% -5.19 pts vs SPY Session 2026-10-30 |
Q2 FY2026 2026-07-30 | 0.92 / 0.24 +289.3%†¶ | $361M / $299M +20.7%¶ | -9.94% -10.66 pts vs SPY Session 2026-07-31 |
Q1 FY2026 2026-05-07 | -0.03 / -0.45 +93.3%†¶ | $273M / $217M +25.4%¶ | +14.27% +13.44 pts vs SPY Session 2026-05-08 |
Reported / estimate
- Q3 FY2026 · 2026-10-29-6.97%EPS-0.62 / 0.14-532.4%†¶Revenue$358M / $306M+16.8%¶
- Q2 FY2026 · 2026-07-30-9.94%EPS0.92 / 0.24+289.3%†¶Revenue$361M / $299M+20.7%¶
- Q1 FY2026 · 2026-05-07+14.27%EPS-0.03 / -0.45+93.3%†¶Revenue$273M / $217M+25.4%¶
- †Unusually large: likely a one-off gain or charge, so not comparable with consensus
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.